Management of a young HoFH patient during pregnancy using Lipoprotein Apheresis (whole blood): A novel experience
- 18 December 2024
- journal article
- research article
- Published by Elsevier in Transfusion and Apheresis Science
- Vol. 64 (1) , 104062
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- International Atherosclerosis Society guidance for implementing best practice in the care of familial hypercholesterolaemiaNature Reviews Cardiology, 2023
- 2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidanceEuropean Heart Journal, 2023
- Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Ninth Special IssueJournal of Clinical Apheresis, 2023
- Safety of PCSK9 inhibitorsBiomedicine & Pharmacotherapy, 2022
- Statins and other lipid-lowering therapy and pregnancy outcomes in homozygous familial hypercholesterolaemia: A retrospective review of 39 pregnanciesAtherosclerosis, 2018
- Treatment of very preterm preeclampsia via heparin-mediated extracorporeal LDL-precipitation (H.E.L.P.) apheresis: The Freiburg preeclampsia H.E.L.P.-Apheresis studyPregnancy Hypertension, 2018
- Aspirin versus Placebo in Pregnancies at High Risk for Preterm PreeclampsiaNew England Journal of Medicine, 2017
- Lipoprotein apheresis is essential for managing pregnancies in patients with homozygous familial hypercholesterolemia: Seven case series and discussionAtherosclerosis, 2016
- Pregnancy in homozygous familial hypercholesterolemia – Importance of LDL-apheresisAtherosclerosis Supplements, 2015
- LDL-Apheresis: Technical and Clinical AspectsThe Scientific World Journal, 2012